Drug Topics

FEBRUARY 19, 2025

The FDA also granted priority review, with a Prescription Drug User Fee Act target action date of August 19, 2025.

FDA 463

FDA 463

PharmaVoice

FEBRUARY 19, 2025

The Young Institute Pharmaceutical Manufacturing Consortium will research and develop new production technologies.

174

174

Drug Topics

FEBRUARY 19, 2025

Researchers conducted a survey of community pharmacists to understand their use, concerns, and opportunities regarding ChatGPT technology in their practice setting.

315

315

Pharmacy Times

FEBRUARY 19, 2025

Embedding a pharmacist in the dermatology clinic improved clinical and financial outcomes.

139

139

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

FEBRUARY 19, 2025

Researchers measured current pharmacy practices and the future potential of practices geared toward reducing instances of opioid overdose.

Community Pharmacies 247

Community Pharmacies 247

Fierce Healthcare

FEBRUARY 19, 2025

NASHVILLE, TennesseeThe Cleveland Clinic conducted a head-to-head comparison of five AI scribe products from major vendors. It found underlying differences in the technology and variation in how quickly the vendors responded to issues, executives said.

136

136

Fierce Healthcare

FEBRUARY 19, 2025

UnitedHealth Group is rolling out a voluntary separation package to its employees. Estimates say approximately 30,000 employees are eligible for the buyout plan.

Packaging 126

Packaging 126

Drug Topics

FEBRUARY 19, 2025

ASC30, an investigational glucagon-like 1-peptide receptor agonist, demonstrates mean weight reductions from baseline of 4.3% and 6.3% for 2 separate cohorts.

190

190

STAT

FEBRUARY 19, 2025

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. I’ve been bundled up for over 48 hours, bearing through another cold front. Hope everyone is staying warm.

119

119

Pharmacy Times

FEBRUARY 19, 2025

The test offers an accurate, fast, low-cost, and noninvasive tool for early diagnosis of pancreatic ductal adenocarcinoma.

117

117

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

FEBRUARY 19, 2025

Gilead's already dominant position in HIV PrEP could be extended if the FDA approves a new twice-yearly injectable product later this year

FDA 117

FDA 117

Fierce Healthcare

FEBRUARY 19, 2025

In typical "are they, aren't they?" speculation, Walgreens Boots Alliance shares jumped on Tuesday after reports that a take-private deal with Sycamore Partners is still on the table. | Walgreens Boots Alliance shares jumped on Tuesday after reports that a take-private deal with Sycamore Partners is still on the table.

116

116

Pharmaceutical Technology

FEBRUARY 19, 2025

Biogen has entered a collaboration with Stoke Therapeutics to develop and commercialise zorevunersen to treat Dravet syndrome.

111

111

Fierce Healthcare

FEBRUARY 19, 2025

Certified community behavioral health clinics, or CCBHCs, provide evidence-based care for mental illness and substance use disorder. There are hundreds of these centers around the U.S. today.

102

102

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmaceutical Technology

FEBRUARY 19, 2025

MSK plans to speed up early-stage drug development by using AWS Drug Discovery Workbench to screen potential candidates.

109

109

STAT

FEBRUARY 19, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! Please send thoughts and prayers that I don’t fall flat on my back walking on ice today during my commute.

102

102

PhRMA

FEBRUARY 19, 2025

I first joined the health care industry in the early 2000s. At that time, the Human Genome Project had yet to be completed. Concepts like immunotherapy, gene therapy and CAR-T were barely an idea. And there were few treatments for diseases like Hepatitis C, melanoma and cystic fibrosis.

100

100

pharmaphorum

FEBRUARY 19, 2025

Explore the potential impact of increased patient involvement in clinical trials and the importance of diversity in research as we look ahead to 2025.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

FEBRUARY 19, 2025

Using new treatment advances, traditional medications, genetic profiles, immunotherapies, and individualized plans enables providers to improve outcomes for patients with TPBC.

97

97

Fierce Healthcare

FEBRUARY 19, 2025

Sutter Health will invest $1 billion to expand its services across Northern California's East Bay region, including a new flagship campus in Emeryville.

93

93

Pharmacy Times

FEBRUARY 19, 2025

Pharmacists play a vital role in supporting patients with endometriosis through guidance on treatment options and managing side effects.

Patient Care 94

Patient Care 94

Fierce Healthcare

FEBRUARY 19, 2025

Humana's senior-focused primary care division is charting a course for further expansion throughout 2025, the company announced Wednesday. | Humana's senior-focused primary care division is charting a course for further expansion throughout 2025, the company announced Wednesday.

80

80

Pharmacy Times

FEBRUARY 19, 2025

These findings may lead to new therapies to help reduce the risk of heart disease in women who are at risk.

82

82

pharmaphorum

FEBRUARY 19, 2025

Novo Nordisk lawsuit claims KBP concealed clinical data ahead of a $1.

80

80

Fierce Healthcare

FEBRUARY 19, 2025

NASHVILLE, TennesseeThe team at Humana's CenterWell unit has its eye on future growth, and that includes digging into potential use cases for artificial intelligence.

78

78

Pharma Marketing Network

FEBRUARY 19, 2025

Introduction Email marketing remains one of the most powerful tools for pharma brands , helping reach healthcare professionals (HCPs), patients, and stakeholders with tailored messaging. But email marketing campaigns in the pharmaceutical industry come with unique challenges regulatory restrictions, privacy concerns, and engagement barriers. How can pharma marketers craft high-performing email marketing campaigns while staying compliant?

HIPAA 72

HIPAA FDA Labelling Communication 72

Fierce Healthcare

FEBRUARY 19, 2025

The major nonprofit health system reversed the prior year's losses despite "considerable challenges" around inflationary expenses and payer reimbursement.

76

76

pharmaphorum

FEBRUARY 19, 2025

In his maiden speech, HHS Secretary RFK Jr says he will investigate the role of childhood vaccines and other 'taboo' topics in chronic disease

Vaccines 71

Vaccines 71

Pharmacy Times

FEBRUARY 19, 2025

Treatment selection includes patient factors, cost, adverse effects, and drug interactions.

65

65

pharmaphorum

FEBRUARY 19, 2025

Biogen has bolstered its pipeline by licensing ex-US rights to a drug for Dravet syndrome a rare form of epilepsy from Stoke Therapeutics

69

69

Pharmacy Times

FEBRUARY 19, 2025

Many patients may struggle to understand the complex immunization schedules compiled by the CDC.

Vaccines 65

Vaccines Immunization 65

pharmaphorum

FEBRUARY 19, 2025

Supernus Pharma has suffered a blow to its R&D pipeline after a candidate for treatment-resistant depression failed a phase 2b trial

66

66

Pharmacy Times

FEBRUARY 19, 2025

Coinfection with RSV and hRV is linked to a higher prevalence of lower respiratory tract infections, according to new data.

65

65